Pharmacological profile of 6,12-dihydro-3-methoxy-1-benzopyrano[3,4-b] [1,4]benzothiazin-6-one, a novel human estrogen receptor agonist

Biological & Pharmaceutical Bulletin
Yves JacquotAlain Xicluna

Abstract

Pharmacological studies were carried out to characterize further the endocrinological profile and the binding mode to the estrogen receptor (ER) of 6,12-dihydro-3-methoxy-1-benzopyrano[3,4-b][1,4]benzothiazin-6-one (1). Binding experiments were conducted with highly purified recombinant human estrogen receptors hERa and beta. Potent estrogenic activity of compound 1 was assessed by testing its ability to down-regulate ERs and to enhance estrogen receptor element (ERE)-dependent transcription. The latest step of our work dealt with the synthesis of the 9-fluorinated derivative 15 for ionic microscopy experiments to determine the intracellular localization of compound 1. Although 1 failed to compete with [3H]E2 for binding to both ER isoforms, evidence was reported that it interacted with hERalpha in MCF-7 cells (ER down-regulation/ERE-dependent luciferase induction). Hence, an appropriate conformation of the hormone binding domain, most probably conferred by co-regulators of ER, is required for the onset of an activity of the compound 1. Estrogenic activity was weak but on the order of magnitude of that of coumestrol (slightly weaker). The synthesis of the 9-methoxylated derivative 16 and its pharmacological evaluation led us to...Continue Reading

References

Jan 1, 1994·The Journal of Steroid Biochemistry and Molecular Biology·Y Maaroufi, G Leclercq
Feb 1, 1996·The Journal of Steroid Biochemistry and Molecular Biology·M BorrásG Leclercq
Apr 1, 1996·Steroids·M BeatoM Truss
Apr 1, 1997·Current Opinion in Cell Biology·C K GlassM G Rosenfeld
Oct 24, 1997·Nature·A M BrzozowskiM Carlquist
Sep 1, 1993·The Journal of Steroid Biochemistry and Molecular Biology·E DemirpenceM Pons
Jan 15, 1999·Journal of Medicinal Chemistry·M SatoC H Turner
Apr 27, 1999·FEBS Letters·A El Khissiin, G Leclercq
Jul 16, 1999·Steroids·R Kumar, E B Thompson
Jul 27, 1999·The Journal of Steroid Biochemistry and Molecular Biology·N J McKennaB W O'Malley
May 20, 2000·Bioorganic & Medicinal Chemistry·S H Kim, J A Katzenellenbogen
Sep 2, 2000·The Journal of Organic Chemistry·G A Kraus, N Zhang
Sep 16, 2000·Breast Cancer Research and Treatment·R S ZandE P Diamandis
Oct 12, 2000·Molecular and Cellular Endocrinology·H S SeoG Leclercq
Oct 21, 2000·Progress in Neurobiology·L M Garcia-SeguraL L DonCarlos
Feb 13, 2001·The Journal of Steroid Biochemistry and Molecular Biology·B S KatzenellenbogenJ A Katzenellenbogen
Mar 10, 2001·Trends in Pharmacological Sciences·G A GrayJ R Seckl
Apr 20, 2001·European Journal of Medicinal Chemistry·Y JacquotA Xicluna
Dec 26, 2001·Chemical Reviews·H GaoC Hansch

❮ Previous
Next ❯

Citations

Jul 13, 2016·Journal of Receptor and Signal Transduction Research·Guy LeclercqYves Jacquot
Jan 1, 2011·International Journal of Medicinal Chemistry·Mustapha El BakkaliBernard Refouvelet

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.